Continental breakfast and networking

Opening comments from Oregon Bioscience Chairman, Bill Newman

State of the Association from the Oregon Bioscience Association - Executive Director, Bob Lanier

Keynote: How Oregon works as the U.S. base for an international medical instrumentation firm – Jake Langer, President of Biotronik USA

Biotronik will share how locating in Oregon has lead to strong growth and high value employees. En pointe will be discussion of the challenges and positives of operating in Oregon, and what needs to be done to attract more Biotroniks.

Panel: Economic Mega-regions - Where Does Oregon Fit?

The concept of the national economy is being eclipsed by the more relevant "Mega-Regional Economic Model" where economic clusters and synergies follow along geographic space that is greater than any single metropolitan area. If the Northwest mega-regional economy can be defined as extending from British Columbia to San Francisco, what is Oregon’s slice of that pie? If no sub-region can do all areas well, what should Oregon’s bioscience cluster focus on? Should we get involved in a talent arms race? What are the high growth areas now, and what are they likely to be going forward?

Moderator: Sarah Garrison, Business Development Officer, Oregon Economic & Community Development Department

Panelist 1: Tim Priest - President/CEO, Greenlight Greater Portland
Panelist 2: Joe Cortright - Economist, Impresa Consulting
Panelist 3: Sandy Shotwell – Principal, Alta Biomedical

Oregon Bioscience in 2020: Emerging Market Value of Oregon's Native Assets

Health care products are moving ever closer to treating each patient uniquely. These integrate sensors and information technology with biochemistry and genetics to produce targeted diagnostics and treatment given genetic type, patient history and environmental influences. Therapy development will be increasingly managed via virtual companies that contract out all functions once they have a candidate drug, device or service. These factors play to Oregon’s strengths and native assets. This panel, addressing this opportunity Oregon has to acquire a leadership position, will discuss virtual bioscience, the business model and go-to-market strategy; define how efforts are anticipating future directions of health care and review what will accelerate these developments.

Moderator: Arundeep Pradhan, OHSU Technology Collaborations
Panelist 1: The future of biotechnology - Andy Goldstein, Artielle Immunotherapeutics
Panelist 2: The future of monitoring patients - Tamara Hayes, Oregon Center for Aging Technologies
Panelist 3: The future of diagnostics - Bob Buck,LABfx and QuantRx

Lunch and Keynote - Allen Alley

Oregon businessman and candidate for state treasurer Allen Alley will describe how Oregon can realize a broadened vision for our economy, and the role of Oregon's life science industry in this vast opportunity. As former CEO of Pixelworks, Gov. Ted Kulongoski’s former economic advisor, and the founding chair of the Oregon Council for Knowledge and Economic Development (now Oregon InC.), Alley brings a comprehensive perspective to the economic landscape of Oregon.

Action items for Oregon's bioscience indstury - Martin Medeiros, Swider Medeiros Haver LLP

What is the blueprint for measured progress in 2008 and 2009? Learn about this year’s successes and the action items in play to capitalize on the radical demographic and bioscience shifts already taking place in our emerging economy. Discussion will entail the financial and management elements required, review of Oregon’s 2007 intellectual property metrics, and capture strategies for new technology transfer and intellectual property. Hear the call on how to succeed in state, local and national legislatures to move policy forward and funding opportunities to the fore.